Grifols Pharmaceutical Technology (Shanghai) Co. Ltd

Grifols China representative office was established in 2010 and obtained the trading license as Grifols Pharmaceutical Technology (Shanghai) Co. Ltd. In 2016. Based in Shanghai, with a branch office in Beijing, we cover mainland China market.

We offer a comprehensive portfolio of Grifols Biopharma and Diagnostic products and services, including Human Albumin, Immunohematology and NAT testing products. Safety and quality are our top priorities as we deliver on our mission to improving the health and well-being of people around the world.

Grifols China News and Updates

Grifols completes sale of a 20% equity stake in SRAAS and forges strategic alliance with Haier Group June 18, 2024
Grifols launches its Erytra Eflexis, a powerful blood-typing system, in China April 29, 2024
Grifols partners with SRAAS to open a new Diagnostic Excellence Center in China September 15, 2022
Grifols appoints Shanghai RAAS exclusive distributor of its NAT solutions in China May 05, 2022
Grifols and partners working together on Plasbumin® for China July 23, 2021

Grifols China

Head Office, Shanghai
Floor 11 - Tower 1, Jing An Kerry Centre,
1515 Nanjing Road West,
Shanghai 200040
PEOPLE'S REPUBLIC OF CHINA

Contact information
Tel +86-21 6020 1510
Fax + 86-21 6119 9158
Mail: grifols.china@grifols.com

Notification of adverse reactions
To report an adverse drug reaction click here

 

 

 

 

Beijing Office
Unit 01A- 01B-02, 15 Floor, West Tower, Twin Towers B12,
Jianguomenwai Avenue,
Chaoyang District
Beijing 100022
PEOPLE'S REPUBLIC OF CHINA

Contact information
Tel. + 86 10 5382 2511
Fax + 86 105382 2520

Local privacy Information
Click here for details

 

 

See on Google Maps

Contact with Grifols

Corp Contact Us

All fields are required unless otherwise stated

0 characters left

Data protection information
Data controller: The Grifols’ group company to which you submit the request. Purpose: To manage your requests of information, suggestions and/or queries. Legal basis: Legitimate interest. Recipients: Grifols’ group companies, Other third parties. Rights: To access, rectify and erase personal data, as well as other rights detailed in the additional information section. Additional information: For additional information on personal data protection check here.

By clicking the button below, I declare being informed that my data is being used as described in the data protection information. In addition, I hereby express my consent by ticking the following checkboxes.

I understand and consent that Grifols may process my personal information (including my sensitive personal information) in accordance with the Privacy Notice and its Chinese Addendum.
I understand and consent that Grifols may transfer and share my personal information, including sensitive personal information, to overseas recipients as provided in Privacy Notice and its Chinese Addendum.

Local privacy information

Additional information to the privacy notices and integral part thereof, when your personal data is processed by any Grifols company in the continental part of the People’s Republic of China

General privacy notice – Additional information
Privacy Notice – Interactions with HCP’s and comercial contacts – Additional information
Privacy notice – Grifols Ethics Helpline - Additional information

Quality policy

The company’s mission and commitment to quality and stakeholder involvement are outlined in its quality policy statement.